Hangyu Li
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Molecular Biology top 5%
- Extracellular vesicles in disease
- RNA modifications and cancer
- Circular RNAs in diseases
Papers in
-
- Extracellular vesicles in disease 8
- Circular RNAs in diseases 6
- RNA Interference and Gene Delivery 5
- RNA modifications and cancer 4
-
- Cancer-related molecular mechanisms research 10
- MicroRNA in disease regulation 8
- Co-authors
- Jingang Liu (20 shared papers)Xueqiang Peng (24 shared papers)Liang Yang (16 shared papers)Yingbo Ma (11 shared papers)Qing Fan (12 shared papers)Shibo Wei (14 shared papers)Shuo Yang (14 shared papers)Xinyu Li (5 shared papers)
- Journals
- Tumor Biology (4 papers)PLoS ONE (3 papers)Medicine (3 papers)Journal of Translational Medicine (3 papers)Cancer Letters (3 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Hangyu Li
98 papers receiving 2.7k citations
Hangyu Li's Hit Papers
Peers
Comparison fields: 5 of 147
- Cancer Research 912
- Molecular Biology 1.4k
- Epidemiology 473
- Immunology 278
- Biochemistry 80
Countries citing papers authored by Hangyu Li
This map shows the geographic impact of Hangyu Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hangyu Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hangyu Li more than expected).
Fields of papers citing papers by Hangyu Li
This network shows the impact of papers produced by Hangyu Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hangyu Li. The network helps show where Hangyu Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Hangyu Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 103 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 227 | |
| 2 | The regulation, function, and role of lipophagy, a form of selective autophagy, in metabolic disorders Hit paper breakdown → | 2022 | 188 |
| 3 | 2018 | 173 | |
| 4 | 2019 | 155 | |
| 5 | 2016 | 134 | |
| 6 | 2019 | 100 | |
| 7 | 2015 | 95 | |
| 8 | 2017 | 82 | |
| 9 | 2023 | 74 | |
| 10 | 2024 | 61 | |
| 11 | 2022 | 61 | |
| 12 | 2014 | 55 | |
| 13 | New insights into autophagy in hepatocellular carcinoma: mechanisms and therapeutic strategies. | 2019 | 52 |
| 14 | 2024 | 50 | |
| 15 | 2022 | 48 | |
| 16 | 2021 | 45 | |
| 17 | 2013 | 44 | |
| 18 | 2020 | 40 | |
| 19 | 2022 | 40 | |
| 20 | 2014 | 37 |
About Hangyu Li
Hangyu Li is a scholar working on Molecular Biology, Cancer Research, Epidemiology, Surgery and Immunology, having authored 103 papers that have together received 2.8k indexed citations. Recurring topics across this work include Autophagy in Disease and Therapy (13 papers), Cancer-related molecular mechanisms research (10 papers), MicroRNA in disease regulation (8 papers), Extracellular vesicles in disease (8 papers), Immunotherapy and Immune Responses (7 papers), Circular RNAs in diseases (6 papers), RNA Interference and Gene Delivery (5 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Cancer Research (912 citations), Molecular Biology (1.4k citations), Epidemiology (473 citations), Immunology (278 citations) and Biochemistry (80 citations). Hangyu Li has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Jingang Liu, Xueqiang Peng, Liang Yang, Yingbo Ma, Qing Fan, Shibo Wei, Shuo Yang, Xinyu Li, Xinyu Li and Liang Yang. Their work appears in journals such as Tumor Biology, PLoS ONE, Medicine, Journal of Translational Medicine and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.